GeneDx Historical Balance Sheet

WGS Stock

96.44 4.15 4.13%

Trend analysis of GeneDx Holdings Corp balance sheet accounts such as Other Current Liabilities of 50.3 M, Total Current Liabilities of 86.7 M, Other Liabilities of 45.5 M or Net Tangible Assets of 306.3 M provides information on GeneDx Holdings' total assets, liabilities, and equity, which is the actual value of GeneDx Holdings Corp to its prevalent stockholders. By breaking down trends over time using GeneDx Holdings balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining GeneDx Holdings Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GeneDx Holdings Corp is a good buy for the upcoming year.

GeneDx Holdings Inventory

14.33 Million

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

About GeneDx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of GeneDx Holdings Corp at a specified time, usually calculated after every quarter, six months, or one year. GeneDx Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of GeneDx Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which GeneDx currently owns. An asset can also be divided into two categories, current and non-current.

GeneDx Holdings Balance Sheet Chart

At this time, GeneDx Holdings' Short and Long Term Debt Total is comparatively stable compared to the past year. Cash is likely to gain to about 130.8 M in 2025, whereas Accounts Payable is likely to drop slightly above 7.6 M in 2025.

Other Current Liab Total Current Liabilities Other Liab Accounts Payable

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on GeneDx Holdings balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of GeneDx Holdings Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents GeneDx Holdings obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of GeneDx Holdings Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from GeneDx Holdings' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into GeneDx Holdings Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	144.3M	58.8M	54.8M	86.7M
Other Current Liabilities	87.4M	44.4M	43.5M	50.3M

Total Current Liabilities Other Current Liab

GeneDx Holdings balance sheet Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Deferred Long Term Liab	Total Current Assets	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Non Current Liabilities Total
Other Current Liab		0.94	0.46	0.73	-0.84	0.52	0.07	0.93	0.39	0.12	0.93	0.9	0.5	0.88	0.88	0.5	0.88	0.34	-0.87	-0.17	0.37	0.75	-0.25	0.14	0.45	-0.9
Total Current Liabilities	0.94		0.42	0.62	-0.63	0.72	0.25	0.8	0.14	0.26	0.9	0.72	0.53	0.67	0.79	0.29	0.75	0.53	-0.71	-0.3	0.45	0.58	-0.48	-0.2	0.46	-0.78
Other Liab	0.46	0.42		-0.08	-0.22	0.3	0.65	0.42	-0.15	0.54	0.47	0.6	0.26	0.38	0.21	0.0	0.19	-0.07	-0.15	-0.19	0.24	0.03	0.01	-0.02	0.24	-0.18
Net Tangible Assets	0.73	0.62	-0.08		-0.82	0.19	-0.51	0.63	0.67	-0.05	0.78	0.64	0.6	0.73	0.94	0.51	0.95	-0.02	-0.92	-0.26	0.48	0.7	0.05	0.37	0.61	-0.95
Retained Earnings	-0.84	-0.63	-0.22	-0.82		0.01	0.42	-0.9	-0.82	0.29	-0.72	-0.83	-0.24	-0.95	-0.86	-0.77	-0.89	0.04	0.97	-0.17	-0.08	-0.92	-0.1	-0.61	-0.24	0.9
Accounts Payable	0.52	0.72	0.3	0.19	0.01		0.66	0.24	-0.53	0.64	0.61	0.34	0.65	0.15	0.36	-0.26	0.31	0.74	-0.14	-0.67	0.64	-0.02	-0.57	-0.68	0.56	-0.32
Other Assets	0.07	0.25	0.65	-0.51	0.42	0.66		-0.07	-0.82	0.7	0.12	0.08	0.2	-0.19	-0.25	-0.52	-0.29	0.44	0.41	-0.4	0.25	-0.45	-0.4	-0.67	0.13	0.29
Net Receivables	0.93	0.8	0.42	0.63	-0.9	0.24	-0.07		0.57	-0.17	0.75	0.87	0.19	0.93	0.75	0.61	0.78	0.27	-0.86	0.17	0.02	0.86	-0.23	0.34	0.14	-0.81
Common Stock Shares Outstanding	0.39	0.14	-0.15	0.67	-0.82	-0.53	-0.82	0.57		-0.62	0.26	0.42	-0.11	0.65	0.55	0.75	0.6	-0.4	-0.75	0.46	-0.24	0.78	0.33	0.82	-0.06	-0.6
Inventory	0.12	0.26	0.54	-0.05	0.29	0.64	0.7	-0.17	-0.62		0.39	0.15	0.74	-0.15	0.12	-0.6	0.06	0.02	0.17	-0.89	0.82	-0.53	-0.14	-0.55	0.73	-0.04
Other Current Assets	0.93	0.9	0.47	0.78	-0.72	0.61	0.12	0.75	0.26	0.39		0.85	0.77	0.76	0.93	0.34	0.9	0.22	-0.82	-0.48	0.67	0.56	-0.14	0.04	0.73	-0.9
Deferred Long Term Liab	0.9	0.72	0.6	0.64	-0.83	0.34	0.08	0.87	0.42	0.15	0.85		0.49	0.95	0.8	0.52	0.84	0.11	-0.82	-0.15	0.33	0.69	0.04	0.4	0.46	-0.83
Total Current Assets	0.5	0.53	0.26	0.6	-0.24	0.65	0.2	0.19	-0.11	0.74	0.77	0.49		0.31	0.67	-0.15	0.64	0.05	-0.42	-0.91	0.98	0.0	-0.03	-0.19	0.99	-0.61
Property Plant Equipment	0.88	0.67	0.38	0.73	-0.95	0.15	-0.19	0.93	0.65	-0.15	0.76	0.95	0.31		0.81	0.67	0.87	0.09	-0.91	0.08	0.13	0.86	0.03	0.56	0.29	-0.87
Total Assets	0.88	0.79	0.21	0.94	-0.86	0.36	-0.25	0.75	0.55	0.12	0.93	0.8	0.67	0.81		0.54	0.99	0.07	-0.95	-0.32	0.56	0.72	0.02	0.28	0.66	-0.98
Short Long Term Debt Total	0.5	0.29	0.0	0.51	-0.77	-0.26	-0.52	0.61	0.75	-0.6	0.34	0.52	-0.15	0.67	0.54		0.55	-0.05	-0.7	0.52	-0.27	0.9	0.44	0.7	-0.14	-0.54
Total Stockholder Equity	0.88	0.75	0.19	0.95	-0.89	0.31	-0.29	0.78	0.6	0.06	0.9	0.84	0.64	0.87	0.99	0.55		0.06	-0.96	-0.28	0.5	0.75	0.03	0.37	0.63	-1.0
Property Plant And Equipment Net	0.34	0.53	-0.07	-0.02	0.04	0.74	0.44	0.27	-0.4	0.02	0.22	0.11	0.05	0.09	0.07	-0.05	0.06		-0.03	-0.07	0.01	0.18	-0.72	-0.57	-0.07	-0.09
Current Deferred Revenue	-0.87	-0.71	-0.15	-0.92	0.97	-0.14	0.41	-0.86	-0.75	0.17	-0.82	-0.82	-0.42	-0.91	-0.95	-0.7	-0.96	-0.03		0.02	-0.27	-0.88	-0.04	-0.49	-0.42	0.97
Net Debt	-0.17	-0.3	-0.19	-0.26	-0.17	-0.67	-0.4	0.17	0.46	-0.89	-0.48	-0.15	-0.91	0.08	-0.32	0.52	-0.28	-0.07	0.02		-0.96	0.4	0.13	0.48	-0.9	0.25
Cash	0.37	0.45	0.24	0.48	-0.08	0.64	0.25	0.02	-0.24	0.82	0.67	0.33	0.98	0.13	0.56	-0.27	0.5	0.01	-0.27	-0.96		-0.16	-0.02	-0.32	0.98	-0.47
Non Current Assets Total	0.75	0.58	0.03	0.7	-0.92	-0.02	-0.45	0.86	0.78	-0.53	0.56	0.69	0.0	0.86	0.72	0.9	0.75	0.18	-0.88	0.4	-0.16		0.06	0.57	-0.02	-0.76
Non Currrent Assets Other	-0.25	-0.48	0.01	0.05	-0.1	-0.57	-0.4	-0.23	0.33	-0.14	-0.14	0.04	-0.03	0.03	0.02	0.44	0.03	-0.72	-0.04	0.13	-0.02	0.06		0.68	0.06	0.04
Long Term Debt	0.14	-0.2	-0.02	0.37	-0.61	-0.68	-0.67	0.34	0.82	-0.55	0.04	0.4	-0.19	0.56	0.28	0.7	0.37	-0.57	-0.49	0.48	-0.32	0.57	0.68		-0.13	-0.34
Cash And Short Term Investments	0.45	0.46	0.24	0.61	-0.24	0.56	0.13	0.14	-0.06	0.73	0.73	0.46	0.99	0.29	0.66	-0.14	0.63	-0.07	-0.42	-0.9	0.98	-0.02	0.06	-0.13		-0.6
Non Current Liabilities Total	-0.9	-0.78	-0.18	-0.95	0.9	-0.32	0.29	-0.81	-0.6	-0.04	-0.9	-0.83	-0.61	-0.87	-0.98	-0.54	-1.0	-0.09	0.97	0.25	-0.47	-0.76	0.04	-0.34	-0.6

Click cells to compare fundamentals

GeneDx Holdings Account Relationship Matchups

GeneDx Holdings balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Current Liab	39.6M	56.1M	87.4M	44.4M	43.5M	50.3M
Total Current Liabilities	73.4M	101.3M	144.3M	58.8M	54.8M	86.7M
Retained Earnings	(330.1M)	(575.4M)	(1.1B)	(1.3B)	(1.4B)	(1.3B)
Accounts Payable	26.7M	44.7M	46.0M	10.2M	8.0M	7.6M
Other Assets	14.4M	7.8M	7.4M	1.0	0.9	0.86
Net Receivables	32.3M	26.6M	43.3M	32.8M	37.6M	35.6M
Common Stock Shares Outstanding	155.48	3.3M	10.2M	24.3M	26.9M	28.2M
Inventory	25.0M	33.5M	13.7M	8.8M	10.7M	14.3M
Other Current Assets	8.7M	23.0M	18.2M	10.6M	8.5M	12.8M
Total Current Assets	174.1M	483.5M	212.6M	182.3M	198.0M	188.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeneDx Historical Balance Sheet

GeneDx Holdings Inventory

14.33 Million

About GeneDx Balance Sheet Analysis

GeneDx Holdings Balance Sheet Chart

Total Current Liabilities

Accounts Payable

GeneDx Holdings balance sheet Correlations

GeneDx Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

GeneDx Holdings balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for GeneDx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 0.99	Total Current Assets
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.98	Total Current Assets
Cash And Short Term Investments	+ 0.98	Cash
Current Deferred Revenue	+ 0.97	Retained Earnings
Non Current Liabilities Total	+ 0.97	Current Deferred Revenue

Non Current Liabilities Total	- 1.0	Total Stockholder Equity
Non Current Liabilities Total	- 0.98	Total Assets
Cash	- 0.96	Net Debt
Current Deferred Revenue	- 0.96	Total Stockholder Equity
Current Deferred Revenue	- 0.95	Total Assets
Property Plant Equipment	- 0.95	Retained Earnings